Literature DB >> 9050929

Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S.

I Yuasa1, K Umetsu, U Vogt, H Nakamura, E Nanba, N Tamaki, Y Irizawa.   

Abstract

The human orosomucoid (ORM) is controlled by two closely linked loci, ORM1 and ORM2, and two tandem genes, AGP1 and AGP2, encoding the proteins produced by the two loci, have been cloned. In this study the molecular basis of ORM1 polymorphism was investigated. For the detection of mutations the products of the six exons of each gene, amplified by the polymerase chain reaction (PCR), were screened by single-strand conformation polymorphism analysis. Subsequently, the exons with an altered migration pattern were gene-specifically amplified by nested PCR. Sequencing of the gene-specific PCR products showed that the three common ORM1 alleles result from A-->G transitions at the codons for amino acid positions 20 in exon 1 and 156 in exon 5 of the AGP1 gene: ORM1*F1 was characterized by CAG (Gln) and GTG (Val), ORM1*F2, by CAG (Gln) and ATG (Met), and ORM1*S, by CGG (Arg) and GTG (Val). The phylogenesis of the genes encoding these three ORM1 alleles is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050929     DOI: 10.1007/s004390050378

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

Review 1.  The role of clinical pharmacology in optimizing antiretroviral therapy.

Authors:  David J Back; Saye H Khoo
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

Review 2.  Orosomucoid, an acute response protein with multiple modulating activities.

Authors:  Zhumin Luo; Hong Lei; Yang Sun; Xia Liu; Ding-Feng Su
Journal:  J Physiol Biochem       Date:  2015-02-25       Impact factor: 4.158

3.  Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage.

Authors:  Lian Sheng Wang; Jing Jing Shang; Shu Ya Shi; Yan Qing Zhang; Jian Lin; Zhi Hua Guo; Yi Chen Wang; Jie Tang; Jie Liu; Ying Zi Liu; Zhi Li; Zhi Rong Tan; Hong Hao Zhou; Hai He Jiang; Hai Tang Xie
Journal:  Eur J Clin Pharmacol       Date:  2012-12-04       Impact factor: 2.953

4.  Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097.

Authors:  Jianmei Wu; Patricia M Lorusso; Larry H Matherly; Jing Li
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

5.  Comparison of methods for the purification of alpha-1 acid glycoprotein from human plasma.

Authors:  Teresa R McCurdy; Varsha Bhakta; Louise J Eltringham-Smith; Sharon Gataiance; Alison E Fox-Robichaud; William P Sheffield
Journal:  J Biomed Biotechnol       Date:  2011-03-08

6.  N-glycan microheterogeneity regulates interactions of plasma proteins.

Authors:  Di Wu; Weston B Struwe; David J Harvey; Michael A J Ferguson; Carol V Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-15       Impact factor: 11.205

Review 7.  An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions.

Authors:  Michel Bteich
Journal:  Heliyon       Date:  2019-11-21

8.  Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients.

Authors:  Vitor Hugo Teixeira; Robert Olaso; Marie-Laure Martin-Magniette; Sandra Lasbleiz; Laurent Jacq; Catarina Resende Oliveira; Pascal Hilliquin; Ivo Gut; François Cornelis; Elisabeth Petit-Teixeira
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

9.  Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan.

Authors:  Wang-Qing Chen; Yan Shu; Qing Li; Lin-Yong Xu; Mary W Roederer; Lan Fan; Lan-Xiang Wu; Fa-Zhong He; Jian-Quan Luo; Zhi-Rong Tan; Yi-Jing He; Hong-Hao Zhou; Xiang Chen; Wei Zhang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.